Skip to main content
IMS Events Main banner

    Jill Corre, PharmD PhD (she/her/hers)

    Medical biologist
    Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France
    Toulouse, Midi-Pyrenees, France

    Jill Corre, PharmD, PhD, graduated from the Pharmaceutical Faculty of Tours in France. She moved to Toulouse where she completed his training as a resident in Medical Biology and specialized in Hematology in the University Hospital. In 2007, she joined the staff of Hematology Laboratory of the University Toulouse Hospital where she is now Professor. Her doctoral thesis was on myeloma microenvironment, in particular on mesenchymal stromal cells. In 2012, she also joined Professor Hervé Avet-Loiseau in the Unit for Genomics in Myeloma, which is now located in the University Cancer Institute of Toulouse Oncopole. She is now head of this lab. Her research activity takes place in the team Pharmacogenomic and Immunology of myeloma, at the Cancer Research Center of Toulouse (U1037 INSERM, co-head with Dr Ludovic Martinet). She is currently an executive member of the Intergroupe Francophone du Myélome and member of the International Myeloma Society.
    She published more than 80 publications, most about Myeloma. She is coauthor of a patent filed under number FR2209990 (method of producing a three-dimensional model of human multiple myeloma). She is specialized in myeloma genomic, in particular prognostic factors.
    She is Head of the second and third year course of blood diseases at the Medecine faculty of Toulouse.
    She has received the “Women in Myeloma" price in 2022.

    Disclosure information not submitted.

    Presentation(s):